ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → 1-morpholin-4-yl-1H-[1,2,3]triazole-4-carboxylic acid {2-oxo-2-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethyl}-amide

HRID 1093849
ノート
印刷プレビュー

反応式

HRID 1093849 の反応式
CCN(C(C)C)C(C)C.[N:10]1([N:16]2[CH:20]=[C:19]([C:21]([OH:23])=O)[N:18]=[N:17]2)[CH2:15][CH2:14][O:13][CH2:12][CH2:11]1.NN1CCOCC1.C1C=CC2N(O)N=NC=2C=1.CCN=C=NCCCN(C)C.Cl.[NH2:53][CH2:54][C:55]([N:57]1[CH2:62][CH2:61][CH:60]([O:63][C:64]2[CH:69]=[CH:68][CH:67]=[C:66]([C:70]([F:73])([F:72])[F:71])[CH:65]=2)[CH2:59][CH2:58]1)=[O:56]>CN(C=O)C.O>[O:56]=[C:55]([N:57]1[CH2:58][CH2:59][CH:60]([O:63][C:64]2[CH:69]=[CH:68][CH:67]=[C:66]([C:70]([F:73])([F:71])[F:72])[CH:65]=2)[CH2:61][CH2:62]1)[CH2:54][NH:53][C:21]([C:19]1[N:18]=[N:17][N:16]([N:10]2[CH2:11][CH2:12][O:13][CH2:14][CH2:15]2)[CH:20]=1)=[O:23]
参加物実験手順後処理出典と根拠反応ノート

参加物

9

反応物 6

HCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 20315N-AminomorpholineHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 665915472-Amino-1-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethanone hydrochlorideHCID 665919181-morpholin-4-yl-1H-[1,2,3]triazole-4-carboxylic acid

生成物 1

HCID 442350261-morpholin-4-yl-1H-[1,2,3]triazole-4-carboxylic acid {2-oxo-2-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethyl}-amide収率 84.7%

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

実験手順

DIPEA (200 mg, 1.54 mmol) was added to a stirred solution of 1-morpholin-4-yl-1H-[1,2,3]triazole-4-carboxylic acid (prepared by the method used for the synthesis of Intermediate 64, starting from 4-aminomorpholine) (70 mg, 0.35 mmol) in DMF (5 mL) followed by HOBt (52 mg, 0.38 mmol) and EDCI (170 mg, 0.88 mmol). After 2 minutes of stirring, 2-amino-1-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethanone hydrochloride (prepared according to Step 1 and 5 of the General Scheme) (120 mg, 0.35 mmol) was added and the resulting mixture was stirred at room temperature overnight. Cold water was then added and the precipitate was collected out. The solid obtained was purified by recrystallisation from a mixture of 20% ethyl acetate in hexane and MeOH to afford 144 mg (84.7% Yield) of 1-morpholin-4-yl-1H-[1,2,3]triazole-4-carboxylic acid {2-oxo-2-[4-(3-trifluoromethyl-phenoxy)-piperidin-1-yl]-ethyl}-amide. LC/MS [M+H]+: 483.19, 92.7%. 1H NMR (300 MHz, DMSO-d6): δ 8.82 (s, 1H), 8.4 (t, 1H), 7.6 (t, 1H), 7.36 (t, 3H), 4.9 (m, 1H), 4.2 (d, 2H), 4.0-3.6 (m, 6H), 3.4 (m, 2H), 3.2 (m, 2H), 2.1 (t, 2H), 1.7 (d, 2H).

後処理

  1. customprepared by the method
  2. additionwas added
  3. stirringthe resulting mixture was stirred at room temperature overnight
  4. customthe precipitate was collected out
  5. customThe solid obtained
  6. customwas purified by recrystallisation from a mixture of 20% ethyl acetate in hexane and MeOH

出典と根拠

ORDレコード
ord-3d80f21d052b4064b1fe38abd679001e
出典データセット
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08129376B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート